Shares of Japan's Eisai swamped with sell orders after ending Alzheimer trials

France Nouvelles Nouvelles

Shares of Japan's Eisai swamped with sell orders after ending Alzheimer trials
France Dernières Nouvelles,France Actualités
  • 📰 Reuters
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 97%

Eisai Co Ltd's shares were untraded on Friday, hit with a glut of sell orde...

The logo of Eisai Co Ltd is displayed at the company headquarters in Tokyo, Japan, March 8, 2018. REUTERS/Issei Kato

The decision, which wiped $18 billion off the value on Biogen on Thursday, marks a major setback in the quest to find a treatment for the mind-wasting disease and came after experts determined the trials had little hope of succeeding.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Reuters /  🏆 2. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Biogen scraps Alzheimer drug trials, shares slump by a quarterBiogen scraps Alzheimer drug trials, shares slump by a quarterBiogen and partner Eisai Co Ltd are ending two late-stage trials testing the exp...
Lire la suite »

Biogen scraps Alzheimer drug trials, wiping $17 billion off its market valueBiogen scraps Alzheimer drug trials, wiping $17 billion off its market valueReuters - Biogen and partner Eisai Co Ltd are ending two late-stage trials for t...
Lire la suite »

Biogen scraps two Alzheimer drug trials, wipes $18 billion from market valueBiogen scraps two Alzheimer drug trials, wipes $18 billion from market valueBiogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their ex...
Lire la suite »

Biogen is crashing after scrapping its late-stage Alzheimer's drug trialsBiogen is crashing after scrapping its late-stage Alzheimer's drug trialsBiogen shares crashed more than 25% in pre-market trading after discontinuing two late-stage Alzheimer's drug trials with Eisai.
Lire la suite »

Biogen's stock plummets after phase 3 trial of Alzheimer's treatment discontinuedBiogen's stock plummets after phase 3 trial of Alzheimer's treatment discontinuedShares of Biogen Inc. plummeted 26% toward a near 3-year low in premarket trade Thursday, after the biotechnology company and Japan's Eisai Co. Ltd. said...
Lire la suite »

Levi Strauss shares surge 31 percent in stock market returnLevi Strauss shares surge 31 percent in stock market returnShares in Levi Strauss & Co surged 31 percent in their debut on Thursday, giving...
Lire la suite »

Levi Strauss & Co. Cl ALevi Strauss & Co. Cl ALevi Strauss & Co. Cl A stock price, stock quotes and financial overviews from MarketWatch.
Lire la suite »

Mom shares why she is never deleting a photo of herselfMom shares why she is never deleting a photo of herselfMarathoner mom opens up about why she no longer deletes any photos of herself: 'I have wasted so much of my life disliking myself for one reason or another.'
Lire la suite »

Chrissy Teigen shares video of son Miles graduating flat head syndrome helmetChrissy Teigen shares video of son Miles graduating flat head syndrome helmetChrissy Teigen took to Twitter last night to wish her son Miles a 'Happy Graduation' after he spent 3 months wearing a helmet for medical reasons.
Lire la suite »



Render Time: 2025-03-11 20:32:13